Although further studies are needed to understand the role of CMC1 in macrophage-derived EVs, finding this protein at lower levels in patients with ICH and infection-related poorer outcomes suggests an uncoupling between the metabolic demands in stressful conditions and the bioavailability of glucose as an energy source, as related to poorer prognosis of these patients. The gene discussed is CMC1; the disease is infection.